SYINSynbio International Inc.

About Synbio International Inc. (SYIN)

Synbio International Inc. (SYIN) is a Health Information Services company headquartered in Sheridan, WY, United States whose shares trade over-the-counter on the Pink tier.

Synbio International Inc (SYIN) aims to enhance patient outcomes and reduce healthcare costs by developing cutting-edge AI-powered methods to aid in the diagnosis of medical conditions. These methods enable early, accurate screening, contributing to quicker and more effective treatment. Synbio also acknowledges the thriving nutraceutical market's potential and plans to enter it for early revenue. The Company will benefit from the growing emphasis on natural approaches and the demand for dietary supplements that offer potential health benefits beyond basic nutrition. The demand for nutraceuticals continues to expand, creating a dynamic landscape for Synbio's nutraceutical businesses to flourish.

Products and services

AI-powered services to aid in the diagnosis of medical conditions. Nutraceuticals based in preventive healthcare.

SYIN key facts

Ticker symbol

SYIN

Market tier

Pink

Sector

Healthcare

Industry

Health Information Services

Headquarters

Sheridan, WY, United States

Country of incorporation

US

Year of incorporation

2002

Employees

1

Estimated market cap

$382.8K (as of Apr 16, 2025)

Shares outstanding

318,996,511

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

Synbio International Inc. leadership

• Claude Solitario — CEO, CFO, Company Secretary
• Jeffrey Don Turner — Legal Counsel

Explore more: Health Information Services stocks · Healthcare sector · Pink stocks · OTC stocks starting with S